Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

When recurrent UTIs might actually be bladder cancer

Fara Bellows, MD
Conditions
September 3, 2025
Share
Tweet
Share

As a urologist, I see recurrent UTI patients nearly every day, and most cases are routine: nasty bacterial infections that appear in the bladder every few months. However, a recent patient turned out to be the zebra rather than the horse. This particularly lovely woman was 91, an Italian immigrant, and was accompanied by her adult son, who helped provide history and translate as needed. She sat calmly on the exam table, her hands resting in her lap, her nails a pristinely manicured siren red. She smiled serenely at me as her son gave her history. “She had her uterus taken out for cancer, and got radiation for it, but she’s been urinating blood for the last 3 years. She keeps getting these bladder infections. They give her antibiotics and it gets better, but this time, it’s not going away. She’s peeing blood and it burns her when she goes to the bathroom.”

My ears prick up at the mention of pelvic radiation. As I scrolled through her CAT scan, I asked gently, “Who are ‘they?'” He waved his hand and responded, “Oh, you know, her primary doctor. He’s been taking care of these infections for the last few years but we thought it was time she saw a specialist.” Between considering her cancer history and the CAT scan materializing in front of me, I note a haziness on the right upper corner of her bladder. These aren’t UTIs, I think to myself. This is bladder cancer.

According to the American Cancer Society, in the year 2025, nearly 20,000 women will be diagnosed with bladder cancer, and nearly 5,000 women will die of it. Risk factors for development of bladder cancer include smoking, workplace exposures (such as aniline dyes), exposure to certain herbal supplements, pelvic radiation, history of receiving cyclophosphamide, and family history of bladder cancer. Presenting symptoms typically include gross hematuria, but may also include urine storage symptoms such as urinary frequency or urgency, or burning with urination. These symptoms can easily be confused with UTIs, especially in women.

There is literature to suggest that women are at higher risk for more aggressive bladder cancer, which may be due to delayed diagnosis. In fact, women appear to be less likely than men to receive a full workup for blood in the urine, or to even receive a referral for urology in the first place. The danger of delayed diagnosis of bladder cancer cannot be understated. In fact, it has been shown that such a delay increases risk of death from bladder cancer.

One may surmise that because of various female-specific conditions such as menstruation, post-menopausal vaginal bleeding, and higher susceptibility to UTIs, women may downplay their symptoms or fail to advocate for themselves to see a specialist. However, for many women who primarily see their primary care physicians or gynecologists for medical care, their symptoms may also be misconstrued as those of typical recurrent UTIs or overactive bladder.

There are a number of possible means we can employ when considering early and timely diagnosis of bladder cancer. Primarily, those in primary care and women’s health must remain vigilant of the possibility of a bladder cancer diagnosis in women, especially for those with visible blood in the urine. Even if culture-proven UTIs are present, these two diagnoses can overlap and a urologic evaluation should be strongly considered.

Furthermore, any patient with risk factors for bladder cancer and visible blood in the urine should probably see a urologist, especially if urine cultures are negative. Only three diagnostic studies are required for anyone who sees blood in the urine: a urine cytology to rule out cancer cells, some form of upper tract imaging (usually renal ultrasound or contrast-enhanced CT scan), and a diagnostic cystoscopy, an office-based test to look inside the bladder to rule out visible tumor. These tests are safe, effective, and low risk, and aside from the cystoscopy, can be ordered by primary care.

Finally, we must remember that bladder cancer can easily mimic a number of more common urologic conditions such as recurrent UTIs and overactive bladder. If there is an index of suspicion, do not hesitate to investigate further. Even a basic renal bladder ultrasound can rule out any gross anatomic abnormalities.

It is essential that we continue to advocate for these women and ensure that they receive the medical care and attention they deserve. The next time you see a woman who is urinating blood, I implore you to think twice before simply treating her with Cipro and sending her on her way until the next time it happens. You could potentially save her life.

Fara Bellows is a urologist.

Prev

How restrictive opioid policies worsen the crisis

September 3, 2025 Kevin 2
…
Next

A step‑by‑step guide to crafting meaningful research questions

September 3, 2025 Kevin 0
…

Tagged as: Urology

Post navigation

< Previous Post
How restrictive opioid policies worsen the crisis
Next Post >
A step‑by‑step guide to crafting meaningful research questions

ADVERTISEMENT

Related Posts

  • AI’s role in streamlining colorectal cancer screening [PODCAST]

    The Podcast by KevinMD
  • Pandemic aftermath: Navigating a new normal in health, education, and social dynamics

    Susan Levenstein, MD
  • Medicare’s 14-day rule is hurting cancer patients

    Sean Jordan, MD
  • Why new cancer treatments cannot save us

    Yongjia Wang
  • Are rapid weight loss drugs hiding the real obesity problem?

    Martha Rosenberg
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD

More in Conditions

  • Why hesitation over the HPV vaccine threatens public health and equity

    Ayesha Khan
  • Why your health is a portfolio to manage

    Larry Kaskel, MD
  • Pain control failures in fertility clinics

    Maire Daugharty, MD
  • Why what you do in midlife matters most

    Michael Pessman
  • Was Viagra the best heart drug we never had?

    Bharat Desai, MD
  • How to stay safe from back-to-school illnesses

    Kevin King, PhD
  • Most Popular

  • Past Week

    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI on social media fuels body dysmorphia

      STRIPED, Harvard T.H. Chan School of Public Health | Policy
    • Physician work-life balance and family

      Francisco M. Torres, MD | Physician
    • Why hesitation over the HPV vaccine threatens public health and equity

      Ayesha Khan | Conditions
    • What psychiatry teaches us about professionalism, loss, and becoming human

      Hannah Wulk | Education
    • How Gen Z is reshaping health care through DIY approaches and digital tools [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
  • Recent Posts

    • How retraining the physician mindset can boost resilience and joy in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI on social media fuels body dysmorphia

      STRIPED, Harvard T.H. Chan School of Public Health | Policy
    • Physician work-life balance and family

      Francisco M. Torres, MD | Physician
    • Why hesitation over the HPV vaccine threatens public health and equity

      Ayesha Khan | Conditions
    • What psychiatry teaches us about professionalism, loss, and becoming human

      Hannah Wulk | Education
    • How Gen Z is reshaping health care through DIY approaches and digital tools [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...